Sunday, August 24, 2008

Pyrolyria and bipolar

from http://www.nutritional-healing.com.au/content/articles-content.php?heading=Pyroluria

Articles
Pyroluria
Pyroluria (originally known as malvaria) is a genetic abnormality in hemoglobin synthesis resulting in a deficiency of zinc and vitamin B6. People with pyroluria produce excess amounts of a byproduct from hemoglobin synthesis, called OHHPL (hydroxyhemoppyrrolin-2-one). In these people an excess amount of pyrrole is found in the urine. Associated changes in fatty acid metabolism lead to low levels of arachidonic acid (an omega-6 fatty acid). The presence of pyroluria can have a profound effect on mental and physical health and was first discovered in relation to schizophrenia.
Pyroluria incidence in different subgroups.
Schizophrenia
27%
Depression
20%
Autism
20%
Bipolar Disorder
18%
General population
10%
Common emotional and physical characteristics of pyroluria.
Little or no dream recall
White spots on finger nails
Poor morning appetite +/- tendency to skip breakfast
Morning nausea
Pale skin +/- poor tanning +/- burn easy in sun
Sensitivity to bright light
Hypersensitive to loud noises
Reading difficulties (e.g. dyslexia)
Poor ability to cope with stress
Mood swings or temper outbursts
Histrionic (dramatic)
Argumentative/enjoy argument
Much higher capability & alertness in the evening, compared to mornings
Poor short term memory
Abnormal body fat distribution
Dry skin
Anxiousness
Significant growth after the age of 16
Articles:
Pyroluria: Hidden Cause of Schizophrenia, Bipolar, Depression, and Anxiety Symptoms by Woody McGinnis, M.D.
Commentary on Nutritional Treatment of Mental Disorders: Pyrrole Disorder by Willam Walsh, Ph.D.
Pyroluria by Carl C. Pfeiffer, Ph.D., M.D.
Pyroluria by Jeremy E. Kaslow, M.D., F.A.C.P., F.A.C.A.A.I.
The Analyst: Pyroluria
Laboratories which test for pyroluria:
Bio-Center Laboratory (Wichita, KS, USA)
Biolab Medical Unit (London, UK)
Direct Healthcare Access, Inc. (Mount Prospect, IL, USA)
Great Plains Laboratory (Lenexa, KS, USA)
Klinisch Ecologisch Allergie Centrum (Weert, Netherlands)
S.A.F.E. Analytical Laboratories (Gold Coast, Australia)
Vitamin Diagnostics (New Jersey, USA)
Related research in chronological order:
The Relationship Between an Unknown Factor (US) in the Urine of Subjects and HOD Test Results. J Neuropsychiatry 2:363-368, 1961. (by Abram Hoffer MD, PhD & Humphry Osmond, M.D.)
The Presence of Unidentified Substances in the Urine of Psychiatric Patients 2:331-362, 1961 (by Abram Hoffer M.D, PhD, et al)
The Presence of Malvaria in Some Mentally Retarded Children. Amer J Ment Def 67:730-732, 1963. (by Abram Hoffer M.D, PhD, et al)
Malvaria: A New Psychiatric Disease. Acta Psychiat Scand 39:335-366, 1963. (by Abram Hoffer MD, PhD & Humphry Osmond, M.D.)
Malvaria and the Law. Psychoso-matics, 7:303-310, 1966. (by Abram Hoffer M.D, PhD, et al)
Mauve spot and schizophrenia. American Journal of Psychiatry 125(6):849-851, 1968.
Biochemical relationship between kryptopyrrole (mauve factor and trans-3-methyl-2-hexenoic acid schizophrenia odor). Res Commun Chem Pathol Pharmacol 1973 (by Carl Pfeiffer MD, PhD, et al.)
Studies on the occurrence of the mauve factor in schizophrenia [article in Polish]. Psychiat. Pol., 7(2):153-9, 1973.
Treatment of pyroluric schizophrenia (malvaria) with large doses of pyridoxine and a dietary supplement of zinc. J. Orthomolecular Psychiatry3(4):292 1974 (by Carl Pfeiffer PhD, MD & Arthur Sohler PhD)
A rapid screening test for pyroluria; useful in distinguishing a schizophrenic subpopulation. J. Orthomolecular Psychiatry 1974 3(4):273 (by Arthur Sohler PhD)
Neurological and behavioral toxicity of kryptopyrrole in the rat., Pharmacol Biochem Behav 3(2):243-50 1975
Zinc and Manganese in the Schizophrenias. J. Orthomolecular Psychiatry 12(3):215 1983 (by Carl Pfeiffer PhD, MD and Scott LaMola, BS)
A new prostaglandin disturbance syndrome in schizophrenia: delta-6-pyroluria., Med Hypotheses 19(4):333-8 1986
Pyroluria – Zinc and B6 deficiencies. Int Clin Nutr Rev 1988 (by Carl Pfeiffer MD, PhD, et al.)
The Discovery of Kryptopyrrole and its Importance in Diagnosis of Biochemical Imbalances in Schizophrenia and in Criminal Behavior J. Orthomolecular Medicine 10(1):3 1995 (by Abram Hoffer M.D, PhD)
Fatty Acid Profiles of Schizophrenic Phenotypes, 91st AOCS Annual Meeting and Expo San Diego, California 2000 (by William Walsh PhD of the Pfeiffer Treatment Center)
Urinary Pyrrole (Mauve Factor): Metric for Oxidative Stress in Behavioral Disorders, presented to the Linus Pauling Institute, 2003 (by Woody R. McGinnis MD)

Blake Graham, BSc (Honours), AACNEM
Clinical Nutritionist
Perth, Western Australia

No comments: